Nucryst announces European approval for Acticoat

Feb. 7, 2006 – Nucryst Pharmaceuticals announced that its Acticoat Moisture Control with Silcryst nanocrystals has received European Design Examination Certificate regulatory approval.

The product, which was cleared by the U.S. Food and Drug Administration and Health Canada in 2005, will be available in Europe commencing March 1, 2006. Acticoat Moisture Control was developed in collaboration between Smith & Nephew and Nucryst Pharmaceuticals and will be sold by Smith & Nephew as part of its Acticoat product line.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.